ARCHIVES

In Brief: NCAB Committee Worried About Requirements for Comprehensive Centers, To Meet Again

This article is from The Cancer Letter archive.

Vol. 14 No. 22 | May 27, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

Ohio Legislature Gives $1 Million To Cancer Control

August 19, 1983

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Cancer Atlast Offers New Research Leads

July 17, 1987

Clinical Trials Approved By NCI Last Month Listed

February 22, 2002

Varmus Projects FY2011 As “Particularly Tight”

November 12, 2010